Ways to Reduce the Risk of Transmission of Viral Infections by Plasma and Plasma Products-Reference-Cited by-同舟云学术

Ways to Reduce the Risk of Transmission of Viral Infections by Plasma and Plasma Products

Published:1988-05 Issue:4 Volume:54 Page:228-245
ISSN:0042-9007
Container-title:Vox Sanguinis
language:en
Short-container-title:

Author:

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1423-0410.1988.tb03910.x/fullpdf

Reference95 articles.

1. 1 Eibl, J. ; Barrett, P.N. ; Dorner, F. Inactivation of HTLV-III/LAV in blood products. 17th Int. Congr. Wld Fed. of Hemophilia, Milan 1986.

2. 2 Unpublished data: Available from Immuno.

3. 3 Hilgartner, M.; the US Feiba Study Group: A study on the safety and efficacy of anti-inhibition coagulant complex, Feiba VH Immuno in hemophilia patients with inhibitors (in preparation).

4. 4 Mannucci, P.M. ; Zanetti, A.R. ; Colombo, M. ; Study Group of the Fondazione dell'Emofilia Differential inactivation of hepatitis B and non-A non-B viruses in a factor-VIII concentrate exposed to hot vapor (submitted).

5. 5 Giusti, G. ; Galanti, B. ; Ruggiero, G. ; Piccinino, F. ; Sagnelli, E. Epidemiology of viral hepatitis in Italy (Abstract No. 382). 9th Int. Congr. Infect. Paras. Dis., Munich 1986.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treating Hemophilia by Gene Therapy;Translating Regenerative Medicine to the Clinic;2016

2. Infection with hepatitis B and C viruses and human retroviruses (HTLV-I and HIV) among high-risk Lebanese patients;Annals of Tropical Medicine & Parasitology;2003-03

3. The Use of Chromatography to Manufacture Purer and Safer Plasma Products;Biotechnology and Genetic Engineering Reviews;2000-08

4. Virussicherheit von Gerinnungspräparaten;Fachübergreifende Aspekte der Hämostaseologie;1994

5. Recent evolution of clotting factor concentrates for hemophilia A and B. Transfusion Practices Committee;Transfusion;1993-05